Cargando…

Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients

BACKGROUND: Folliculotropic mycosis fungoides (FMF) is a distinct variant of mycosis fungoides. Recent studies recognized indolent and aggressive subgroups of FMF, but there is controversy how patients presenting with plaques should be classified. The present study describes the histopathologic feat...

Descripción completa

Detalles Bibliográficos
Autores principales: van Santen, Suzanne, Jansen, Patty M., Quint, Koen D., Vermeer, Maarten H., Willemze, Rein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028105/
https://www.ncbi.nlm.nih.gov/pubmed/31755567
http://dx.doi.org/10.1111/cup.13615
_version_ 1783498959234269184
author van Santen, Suzanne
Jansen, Patty M.
Quint, Koen D.
Vermeer, Maarten H.
Willemze, Rein
author_facet van Santen, Suzanne
Jansen, Patty M.
Quint, Koen D.
Vermeer, Maarten H.
Willemze, Rein
author_sort van Santen, Suzanne
collection PubMed
description BACKGROUND: Folliculotropic mycosis fungoides (FMF) is a distinct variant of mycosis fungoides. Recent studies recognized indolent and aggressive subgroups of FMF, but there is controversy how patients presenting with plaques should be classified. The present study describes the histopathologic features of 40 FMF plaques. The aim of the study was to identify risk factors for disease progression and poor outcome in this group. METHODS: Clinical, histopathological, and immunophenotypical data from 40 patients with plaque stage FMF were reviewed and analysed for risk factors for disease progression and survival. RESULTS: After a median follow‐up of 80 months, disease progression occurred in 20 of 40 patients. Percentage of atypical cells, cell size, percentage of Ki‐67+ cells, and co‐existent interfollicular epidermotropism, but not the extent of perifollicular infiltrates, were associated with disease progression and reduced survival, while extensive follicular mucinosis was associated with increased survival. CONCLUSIONS: This study underlines that FMF patients presenting with plaques represent a heterogeneous group and that a subgroup of these patients may have an indolent clinical course. It further shows that histological examination is a valuable tool to differentiate between indolent and aggressive disease.
format Online
Article
Text
id pubmed-7028105
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-70281052020-02-25 Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients van Santen, Suzanne Jansen, Patty M. Quint, Koen D. Vermeer, Maarten H. Willemze, Rein J Cutan Pathol Original Articles BACKGROUND: Folliculotropic mycosis fungoides (FMF) is a distinct variant of mycosis fungoides. Recent studies recognized indolent and aggressive subgroups of FMF, but there is controversy how patients presenting with plaques should be classified. The present study describes the histopathologic features of 40 FMF plaques. The aim of the study was to identify risk factors for disease progression and poor outcome in this group. METHODS: Clinical, histopathological, and immunophenotypical data from 40 patients with plaque stage FMF were reviewed and analysed for risk factors for disease progression and survival. RESULTS: After a median follow‐up of 80 months, disease progression occurred in 20 of 40 patients. Percentage of atypical cells, cell size, percentage of Ki‐67+ cells, and co‐existent interfollicular epidermotropism, but not the extent of perifollicular infiltrates, were associated with disease progression and reduced survival, while extensive follicular mucinosis was associated with increased survival. CONCLUSIONS: This study underlines that FMF patients presenting with plaques represent a heterogeneous group and that a subgroup of these patients may have an indolent clinical course. It further shows that histological examination is a valuable tool to differentiate between indolent and aggressive disease. Blackwell Publishing Ltd 2019-12-09 2020-03 /pmc/articles/PMC7028105/ /pubmed/31755567 http://dx.doi.org/10.1111/cup.13615 Text en © 2019 The Authors. Journal of Cutaneous Pathology published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
van Santen, Suzanne
Jansen, Patty M.
Quint, Koen D.
Vermeer, Maarten H.
Willemze, Rein
Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
title Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
title_full Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
title_fullStr Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
title_full_unstemmed Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
title_short Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
title_sort plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028105/
https://www.ncbi.nlm.nih.gov/pubmed/31755567
http://dx.doi.org/10.1111/cup.13615
work_keys_str_mv AT vansantensuzanne plaquestagefolliculotropicmycosisfungoideshistopathologicfeaturesandprognosticfactorsinaseriesof40patients
AT jansenpattym plaquestagefolliculotropicmycosisfungoideshistopathologicfeaturesandprognosticfactorsinaseriesof40patients
AT quintkoend plaquestagefolliculotropicmycosisfungoideshistopathologicfeaturesandprognosticfactorsinaseriesof40patients
AT vermeermaartenh plaquestagefolliculotropicmycosisfungoideshistopathologicfeaturesandprognosticfactorsinaseriesof40patients
AT willemzerein plaquestagefolliculotropicmycosisfungoideshistopathologicfeaturesandprognosticfactorsinaseriesof40patients